» Articles » PMID: 9430698

Cell Lines from Kidney Proximal Tubules of a Patient with Lowe Syndrome Lack OCRL Inositol Polyphosphate 5-phosphatase and Accumulate Phosphatidylinositol 4,5-bisphosphate

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 1998 Jan 27
PMID 9430698
Citations 62
Authors
Affiliations
Soon will be listed here.
Abstract

The protein product of the gene that when mutated is responsible for Lowe syndrome, or oculocerebrorenal syndrome (OCRL), is an inositol polyphosphate 5-phosphatase. It has a marked preference for phosphatidylinositol 4,5-bisphosphate although it hydrolyzes all four of the known inositol polyphosphate 5-phosphatase substrates: inositol 1,4,5-trisphosphate, inositol 1,3,4,5-tetrakisphosphate, phosphatidylinositol 4,5-bisphosphate, and phosphatidylinositol 3,4,5-trisphosphate. The enzyme activity of this protein is determined by a region of 672 out of a total of 970 amino acids that is homologous to inositol polyphosphate 5-phosphatase II. Cell lines from kidney proximal tubules of a patient with Lowe syndrome and a normal individual were used to study the function of OCRL. The cells from the Lowe syndrome patient lack OCRL protein. OCRL is the major phosphatidylinositol 4,5-bisphosphate 5-phosphatase in these cells. As a result, these cells accumulate phosphatidylinositol 4,5-bisphosphate even though at least four other inositol polyphosphate 5-phosphatase isozymes are present in these cells. OCRL is associated with lysosomal membranes in control proximal tubule cell lines suggesting that OCRL may function in lysosomal membrane trafficking by regulating the specific pool of phosphatidylinositol 4,5-bisphosphate that is associated with lysosomes.

Citing Articles

Phosphoinositide switches in cell physiology - From molecular mechanisms to disease.

Lolicato F, Nickel W, Haucke V, Ebner M J Biol Chem. 2024; 300(3):105757.

PMID: 38364889 PMC: 10944118. DOI: 10.1016/j.jbc.2024.105757.


Participation of OCRL1, and APPL1, in the expression, proteolysis, phosphorylation and endosomal trafficking of megalin: Implications for Lowe Syndrome.

Sandoval L, Fuentealba L, Marzolo M Front Cell Dev Biol. 2022; 10:911664.

PMID: 36340038 PMC: 9630597. DOI: 10.3389/fcell.2022.911664.


Assessment of endocytic traffic and Ocrl function in the developing zebrafish neuroepithelium.

Williams D, Gungordu L, Jackson-Crawford A, Lowe M J Cell Sci. 2022; 135(18).

PMID: 35979861 PMC: 9592051. DOI: 10.1242/jcs.260339.


An Emerging Role for Phosphoinositides in the Pathophysiology of Parkinson's Disease.

Schechter M, Sharon R J Parkinsons Dis. 2021; 11(4):1725-1750.

PMID: 34151859 PMC: 8609718. DOI: 10.3233/JPD-212684.


Phosphoinositide lipids in primary cilia biology.

Conduit S, Vanhaesebroeck B Biochem J. 2020; 477(18):3541-3565.

PMID: 32970140 PMC: 7518857. DOI: 10.1042/BCJ20200277.